eMedicine Specialties > Dermatology > Diseases of the Adnexa

Congenital Hypertrichosis Lanuginosa

Author: Sarah K Taylor, MD, Resident Physician, Department of Dermatology, Walter Reed Army Medical Center and National Naval Medical Center
Coauthor(s): Kenneth J Galeckas, MD, Assistant Professor, Department of Dermatology, Uniformed Services University of the Health Sciences; Staff Dermatologist, Director, Laser and Cosmetic Clinic, Intern and Medical Student Coordinator, Department of Dermatology, National Naval Medical Center
Contributor Information and Disclosures

Updated: Jun 18, 2009

Introduction

Background

For hundreds of years, societies have maintained a certain fascination with the bizarre and the unknown. In the past, persons with congenital disorders that cause excessive body-hair growth have been so dramatized and romanticized that individuals with rare hypertrichosis syndromes became crowd-drawing money-making phenomena in many 19th century sideshow acts. Most famously, Fedor Jeftichew, aka Jojo the Dog-faced boy, was exhibited by PT Barnum in the US in the 1800's.

These individuals have been referred to as dog-men, hair-men, human Skye terriers, ape-men, werewolves, and Homo sylvestris.1,2 Since the Middle Ages, approximately 50 individuals with congenital hypertrichosis have been described, and, according to the most recent estimates, approximately 34 cases are documented adequately and definitively in the literature .3

Disorders of hypertrichosis are distinguished by the distribution of hair, as well as by the temporal pattern of growth, the possible associated congenital anomalies, and the possible inheritance pattern.

Congenital hypertrichosis lanuginosa (CHL) has been referred to variably as congenital hypertrichosis universalis, hypertrichosis universalis, hypertrichosis lanuginosa, and hypertrichosis lanuginosa universalis. The lack of definitive terminology can be confusing and may make the distinction of the related but unique hypertrichosis syndromes difficult .1,2,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 Several solitary case reports describing hypertrichosis resembling congenital hypertrichosis lanuginosa in association with other physical findings may, in fact, represent variants in a spectrum of the disorder.

An X-linked syndrome of hypertrichosis associated with gingival hyperplasia has been described. The abnormally excessive body hair that these patients develop is of the terminal type, and this disorder will not be greatly discussed. However, the X-linked syndrome of hypertrichosis associated with gingival hyperplasia is often confused with congenital hypertrichosis lanuginosa. Of interest, Julia Pastrana (1834-1860), one of the most famous persons with generalized hypertrichosis, was long thought to have congenital hypertrichosis lanuginosa. After her death, her hairs were found to actually be terminal in nature, indicating that she likely had hypertrichosis with gingival hyperplasia and not congenital hypertrichosis lanuginosa. This illustrates the need to accurately determine the type of excess hair present on a given patient.

In addition, the localized hypertrichoses, including primary hypertrichosis cubiti (hypertrichosis of both elbows), primary cervical hypertrichosis, and primary faun tail deformity, are not addressed in this article .20 These forms represent limited types of hypertrichosis that may be associated with underlying bone and neurologic abnormalities. Hence, they can be distinguished from congenital hypertrichosis lanuginosa on the basis of their clinical presentations.

In 1648, Aldrovandus first documented a family with hypertrichosis. Originally from the Canary Islands, Petrus Gonzales was brought to France as a curiosity for the nobles. He, his 2 daughters, a son, and a grandchild were affected. This kindred was dubbed the Family of Ambras after a castle near Innsbruck where their portraits were discovered. Over the next 300 years, more than 50 similar-appearing cases were described, and 34 patients with presumed congenital hypertrichosis were identified. In 1873, Virchow described an edentate form; in 1876, Bartles added the descriptor "universalis;" and, in 1890, Chiari called the syndrome "hypertrichosis of the dog-men."


Family of Petrus Gonzales, who lived in the 16th ...

Family of Petrus Gonzales, who lived in the 16th century.

Family of Petrus Gonzales, who lived in the 16th ...

Family of Petrus Gonzales, who lived in the 16th century.

The hairy family of Burma has a 4-generation pedigree of congenital hypertrichosis lanuginosa dating back to 1826. Earlier generations were in the employ of the Ava court, but later generations often earned a living as sideshow attractions in the 1880s.

In 1993, Baumeister et al noted that 9 of these 34 patients with hypertrichosis had a distinctive clinical presentation.3 The term Ambras syndrome was coined, and subsequent genetic analyses in 2 patients have revealed an association with a paracentric inversion of band 8q22.


Patients in well-documented cases of Ambras syndr...

Patients in well-documented cases of Ambras syndrome. (A) Daughter of Petrus Gonzales. (B) Grandson of Schwe Maong. (C) Adrrian Jepticheff. (D) Fedor.

Patients in well-documented cases of Ambras syndr...

Patients in well-documented cases of Ambras syndrome. (A) Daughter of Petrus Gonzales. (B) Grandson of Schwe Maong. (C) Adrrian Jepticheff. (D) Fedor.

Pathophysiology

Two types of excessive hair disorders exist and must be distinguished.

Hypertrichosis is non–androgen-related pattern of excessive hair growth that may involve vellus, terminal, or lanugo type hair. Hypertrichosis can accompany certain genetic syndromes, or it can be induced secondarily by exogenous medications, most notably phenytoin, minoxidil, cyclosporine, diazoxide, corticosteroids, phenytoin (Dilantin), streptomycin, hexachlorobenzene, penicillamine, heavy metals, sodium tetradecyl sulfate, acetazolamide, and interferon.

The hypertrichosis seen in Ambras syndrome is believed to result either from an increase in the number of hairs in anagen or from an increased number of follicular units, although no one knows for certain.

Alternatively, hirsutism commonly occurs in women and presents as androgen-induced male-pattern hair growth of the terminal type. Hirsutism may have a congenital or exogenous origin. More common causes of hirsutism include polycystic ovary syndrome (PCOS), idiopathic hirsutism, hyperprolactinemia, hyperthecosis, and medications (eg, danazol, androgenic oral contraceptives). Less common causes of hirsutism include congenital adrenal hyperplasia, ovarian tumors, Sertoli-Leydig cell tumors, granulosa–thecal cell tumors, other tumors that stimulate the ovarian stroma, adrenal tumors, Cushing disease, tumors of the adrenal cortex, and severe insulin-resistance syndromes.

Frequency

United States

Congenital hypertrichosis lanuginosa and Ambras syndrome are extremely rare.

International

Congenital hypertrichosis lanuginosa and Ambras syndrome are extremely rare. Fewer than 50 cases are documented worldwide .2,3,21,22 The incidence of congenital hypertrichosis lanuginosa is unknown; however, reported incidence ranges from 1 in a billion to 1 in 10 billion .4,18,23,24

Congenital hypertrichosis lanuginosa and Ambras syndrome have no geographic predilection.

Mortality/Morbidity

  • Congenital hypertrichosis lanuginosa is not associated with an increased mortality rate.
  • No documented long-term medical or physical morbidities are associated with congenital hypertrichosis lanuginosa.
  • Psychological sequelae may occur because of the presence of excessive hair growth and the maintenance involved with removing the unwanted hair.

Race

No racial predilection is recognized.

Sex

No sex predilection is known.

Age

In both congenital hypertrichosis lanuginosa and Ambras syndrome, excessive hair is apparent at birth.

  • Patients with congenital hypertrichosis lanuginosa have growth of the lanugo hair, which increases in length and extent of involvement from birth to approximately age 2 years (range, 1-8 y). As a result, the density, length, and extent of involvement may decrease; the rate of hair growth also slows. Many individuals with congenital hypertrichosis lanuginosa lose most, if not all, of their lanugo hair over time, and eventually, only limited areas of hypertrichosis may be present. Occasionally, the lanugo hair may be totally lost by the time the patient becomes an adult. A variant in which patients do not lose their lanugo hair over time is called congenital hypertrichosis universalis or persistent hypertrichosis universalis .25
  • Individuals with Ambras syndrome are classically described as having hypertrichosis at birth; however, the quantity of the excessive hair may be limited at that time. Unlike congenital hypertrichosis lanuginosa, Ambras syndrome may show increased hair growth in both distribution and density as the patient ages, and the hair does not spontaneously involute.

Clinical

History

The presenting complaint in congenital hypertrichosis lanuginosa (CHL) is an excess of body hair.

  • Patients with congenital hypertrichosis lanuginosa are otherwise asymptomatic.
  • Patients with Ambras syndrome may complain of dysmorphic features of the face. These features do not impair function.
  • A family history of excessive body hair may exist.
  • No abnormalities in psychomotor, intellectual, or psychological development are known to occur.

Physical

Both congenital hypertrichosis lanuginosa and Ambras syndrome share the characteristic of abnormally excessive hair growth with a consistent pattern of areas that are spared. In both disorders, hair is found only in areas where it is usually present. The palms, soles, mucous membranes, dorsal terminal phalanges, labia minora, prepuce, and glans penis are spared .19

  • Congenital hypertrichosis lanuginosa
    • In congenital hypertrichosis lanuginosa, most of the body is covered with fine, blond or nonpigmented hair at birth. These hairs may reach up to 10 centimeters and often blend with the darker, terminal hairs of the scalp and/or eyebrows. Whorls of hair may be noted around the sacrum, preauricular region, and pinnae.
    • The length of the hair and its distribution may continue to increase until the individual is aged approximately 2 years. By adulthood, patients typically lose some or all of their excessive lanugo hair.
    • No abnormalities of other organ systems are associated with congenital hypertrichosis lanuginosa, although solitary case reports note abnormalities such as delayed tooth eruption, diffuse hamartoma of the arrector muscles, supernumerary teeth, glaucoma, pyloric stenosis, growth and/or developmental delay, aortic and cardiac valve abnormalities (including tetralogy of Fallot), and macromastia .13,15,18,26,27,28
  • Ambras syndrome
    • The entire body is covered with long, fine vellus hair, which spares only the palms, soles, and genitalia. The hypertrichosis characteristically involves the shoulders, face, nose, and ears. In some areas, the hair may be noted as long as several centimeters.
    • The forehead, eyelids, nose, cheeks, and preauricular regions are uniformly covered with hair, which can reach a length of several decimeters. The hair is longest over the spine. Most patients have hair in a characteristic shawl distribution on their back.
    • The hair of the external auditory canal is typically long and thick, and it may hinder inspection of the auditory meatus.
    • Abnormalities of the teeth may be present. Adontia may occur, with an absence of the upper molars and the premolar teeth and a lag in the development of the first and second dentition.
    • Features associated with facial dysmorphism include the following:
      • Triangular, coarse face
      • Large intercanthal distance
      • Broad palpebral fissures
      • Long, prominent back of the nose and a round nose tip
      • Large interalar distance
      • Anteverted nares
      • Short integumental lower lip
      • Flat sulcus mentolabialis
    • Other findings noted in solitary case reports include the following:
      • Bushy eyebrows with hair darker and coarser than that of the rest of the face, shoulders, body, and extremities
      • Hair on the forearms and legs, in excess of and darker than the rest of the hair on the extremity
      • Six accessory nipples

Causes

  • The pathogenesis of congenital hypertrichosis lanuginosa is unknown.
    • Congenital hypertrichosis lanuginosa is believed to be inherited in an autosomal dominant manner; most cases involve a familial component. Variable expressivity of inherited characteristics is noted.
    • The specific genetic abnormality in congenital hypertrichosis lanuginosa has not been defined.
    • No known hormonal or endocrinologic abnormalities have been identified.
    • Evidence suggests that some cases of congenital hypertrichosis lanuginosa are not familial. These cases likely represent spontaneous mutations .4,29
  • A genetic etiology is proposed for Ambras syndrome.
    • Two cases of Ambras syndrome .3,30 were associated with alterations in chromosome 8. Using fluorescence in situ hybridization (FISH), Tadin et al analyzed the original patient described by Baumeister and detected a pericentric inversion of chromosome 8, inv(8)(p11.2q22).31
    • In an analysis of findings in the second patient reported by Balducci, an association was made with an insertion of the q23-24 region into a more proximal region of the long arm of chromosome 8, most likely at the q13 band, as well as a complex deletion in 8q23 encompassing four separate chromosomal breakpoints.30
    • The inversion breakpoints in this latter patient have been cloned, and a detailed map of the inversion breakpoint interval has been generated .32
    • Some postulated that the common breakpoint in both patients at 8q22 suggests that this region of chromosome 8 contains a gene involved in regulation of hair growth.
    • Although the relationship of these genetic observations to the pathogenesis of hypertrichosis remains uncertain, it has been postulated that the common breakpoint in both patients with Ambras syndrome at 8q22 suggests that this region of chromosome 8 contains a gene involved in regulation of hair growth.

More on Congenital Hypertrichosis Lanuginosa

Overview: Congenital Hypertrichosis Lanuginosa
Differential Diagnoses & Workup: Congenital Hypertrichosis Lanuginosa
Treatment & Medication: Congenital Hypertrichosis Lanuginosa
Follow-up: Congenital Hypertrichosis Lanuginosa
Multimedia: Congenital Hypertrichosis Lanuginosa
References

References

  1. Brandt A. Uber die sogenannten Hundemenschen, beziehungsweise uber Hypertrichosis universalis. Biol Zbl. 1897;17:161-79.

  2. Felgenhauer WR. [Hypertrichosis languinosa universalis]. J Genet Hum. May 1969;17(1):1-44. [Medline].

  3. Baumeister FA, Egger J, Schildhauer MT, Stengel-Rutkowski S. Ambras syndrome: delineation of a unique hypertrichosis universalis congenita and association with a balanced pericentric inversion (8) (p11.2; q22). Clin Genet. Sep 1993;44(3):121-8. [Medline].

  4. Beighton P. Congenital hypertrichosis lanuginosa. Arch Dermatol. Jun 1970;101(6):669-72. [Medline].

  5. Broster LR. Hypertrichosis: a report of three cases. Br Med J. May 20 1950;1(4663):1171-4. [Medline].

  6. Cantu JM, Garcia-Cruz D, Sanchez-Corona J, Hernandez A, Nazara Z. A distinct osteochondrodysplasia with hypertrichosis- Individualization of a probable autosomal recessive entity. Hum Genet. 1982;60(1):36-41. [Medline].

  7. Demikova NS, Blinnikova OE, Udler EE. [A case of congenital generalized hypertrichosis]. Klin Med (Mosk). Mar 1986;64(3):125-6. [Medline].

  8. Freire-Maia N, Felizali J, de Figueiredo AC, Opitz JM, Parreira M, Maia NA. Hypertrichosis lanuginosa in a mother and son. Clin Genet. Nov 1976;10(5):303-6. [Medline].

  9. Gardner AL. A case of hypertrichosis universalis. East Afr Med J. Jul 1964;41:345-6. [Medline].

  10. Jalili IK. Cone-rod congenital amaurosis associated with congenital hypertrichosis: an autosomal recessive condition. J Med Genet. Aug 1989;26(8):504-10. [Medline].

  11. Janssen TAE, De Lange C. Familial congenital hypertrichosis totalis (trichostasis). Acta Paediatr. 1945;33:69-78.

  12. Joest HR. Haarmenschen Ram-a-Samy. Z f Ethnologie. 1984;26:433-5.

  13. Judge MR, Khaw PT, Rice NS, Christopher A, Holmstrom G, Harper JI. Congenital hypertrichosis lanuginosa and congenital glaucoma. Br J Dermatol. May 1991;124(5):495-7. [Medline].

  14. Kint AH, Vermander FR, Decroix JM. [Congenital hypertrichosis lanuginosa]. Hautarzt. Jul 1985;36(7):423-4. [Medline].

  15. Li ZH, Tong ZH, Luo GY, Cai HM. Congenital hypertrichosis universalis associated with gingival hyperplasia and macromastia. Chin Med J (Engl). Nov 1986;99(11):916-7. [Medline].

  16. McKusick VA. Mendelian Inheritance in Man: Catalogs of autosomal dominant, autosomal recessive and X-linked phenotypes. 10th ed. Baltimore: John Hopkins University Press; 1992.

  17. Nowakowski TK, Scholz A. [The fate of people with hypertrichosis throughout history]. Hautarzt. Nov 1977;28(11):593-9. [Medline].

  18. Partridge JW. Congenital hypertrichosis lanuginosa: neonatal shaving. Arch Dis Child. Jun 1987;62(6):623-5. [Medline].

  19. Suskind R, Esterly NB. Congenital hypertrichosis universalis. Birth Defects Orig Artic Ser. Jun 1971;7(8):103-6. [Medline].

  20. Vashi RA, Mancini AJ, Paller AS. Primary generalized and localized hypertrichosis in children. Arch Dermatol. Jul 2001;137(7):877-84. [Medline].

  21. Danforth CH. Studies on hair with special reference to hypertrichosis. Arch Dermatol Syphilol. 1925;12:380-401.

  22. Rook A, Ebling FJG, Champion RH, Burton JL, eds. Textbook of Dermatology. Vol 3. 4th ed. Oxford and Edinburgh: Blackwell Scientific Publications; 1986.

  23. von Luschan F. Ein Haarmensch. Zeitschrift fur Ethnologie. 1907;39:425-9.

  24. Torbus O, Sliwa F. [Ambras syndrome--a form of generalised congenital hypertrichosis]. Pol Merkur Lekarski. Mar 2002;12(69):238-40. [Medline].

  25. Baumeister FA, Schwarz HP, Stengel-Rutkowski S. Childhood hypertrichosis: diagnosis and management. Arch Dis Child. May 1995;72(5):457-9. [Medline].

  26. Franklin DL, Roberts GJ. Delayed tooth eruption in congenital hypertrichosis lanuginosa. Pediatr Dent. May-Jun 1998;20(3):192-4. [Medline].

  27. Larregue M, Vabre P, Cavaroc Y, Duriez P, Matard B. [Diffuse hamartoma of the arrector muscles and congenital hypertrichosis lanuginosa]. Ann Dermatol Venereol. 1991;118(11):796-8. [Medline].

  28. Verloes A, Massin M, Fransolet AC, Misson JP. Hypertrichosis, Fallot tetralogy, growth and developmental delay. Clin Dysmorphol. Oct 2004;13(4):247-50. [Medline][Full Text].

  29. Mendiratta V, Harjai B, Gupta T. Hypertrichosis lanuginosa congenita. Pediatr Dermatol. Jul-Aug 2008;25(4):483-4. [Medline][Full Text].

  30. Balducci R, Toscano V, Tedeschi B, et al. A new case of Ambras syndrome associated with a paracentric inversion (8) (q12; q22). Clin Genet. Jun 1998;53(6):466-8. [Medline].

  31. Tadin M, Braverman E, Cianfarani S, et al. Complex cytogenetic rearrangement of chromosome 8q in a case of Ambras syndrome. Am J Med Genet. Jul 22 2001;102(1):100-4. [Medline].

  32. Tadin-Strapps M, Warburton D, Baumeister FA, et al. Cloning of the breakpoints of a de novo inversion of chromosome 8, inv (8)(p11.2q23.1) in a patient with Ambras syndrome. Cytogenet Genome Res. 2004;107(1-2):68-76. [Medline].

  33. Stengel-Rutkowski S, Murken JD, Pilar V, et al. New chromosomal dysmorphic syndromes. 3. Partial trisomy 3q. Eur J Pediatr. Feb 8 1979;130(2):111-25. [Medline].

  34. Martinez Santana S, Perez Alvarez F, Frias JL, Martinez-Frias ML. Hypertrichosis, atrophic skin, ectropion, and macrostomia (Barber-Say syndrome): report of a new case. Am J Med Genet. Aug 1 1993;47(1):20-3. [Medline].

  35. Belengeanu V, Rozsnyai K, Gug C, Banateanu M, Farcas S, Belengeanu A. Ambras syndrome: report on two affected siblings with no prior family history. Clin Dysmorphol. Oct 2004;13(4):265-7. [Medline].

  36. Baumeister FA, Stengel-Rutkowski S. Differentiation of congenital hypertrichosis from Ambras syndrome. Clin Genet. Dec 1994;46(6):441. [Medline].

  37. Bondeson J, Miles AE. Julia Pastrana, the nondescript: an example of congenital, generalized hypertrichosis terminalis with gingival hyperplasia. Am J Med Genet. Aug 15 1993;47(2):198-212. [Medline][Full Text].

  38. Bondeson J, Miles AE. The hairy family of Burma: a four generation pedigree of congenital hypertrichosis lanuginosa. J R Soc Med. Jul 1996;89(7):403-8. [Medline].

  39. Fred FF. Differential diagnosis of excess hair in women. In: Ferri's Clinical Advisor: Instant Diagnosis and Treatment. St Louis: Mosby; 2001:892.

  40. Littler CM. Laser hair removal in a patient with hypertrichosis lanuginosa congenita. Dermatol Surg. Aug 1997;23(8):705-7. [Medline].

  41. Rashid M Rashid, Lucile E. White. A hairy development in hypertrichosis: a brief review of Ambras syndrome. Dermatology Online Journal [serial online]. 2007;13 (3):8. Available at http://dermatology.cdlib.org/133/reviews/ambras/rashid.html.

  42. Sigalas J, Tabakis T, Skordala M, Nouri M. Congenital Hypertrichosis Universalis. Pediatrica Chronica. 1990;17:181-5.

Further Reading

Keywords

congenital hypertrichosis lanuginosa, CHL, congenital hypertrichosis universalis, hypertrichosis universalis, hypertrichosis lanuginosa universalis, hypertrichosis disorders, hypertrichosis syndromes, Ambras syndrome, persistent hypertrichosis universalis, hirsutism, dog-men, hair-men, human Skye terriers, ape-men, werewolves, Homo silvestris, hypertrichosis of the dog-men, lanugo hair

Contributor Information and Disclosures

Author

Sarah K Taylor, MD, Resident Physician, Department of Dermatology, Walter Reed Army Medical Center and National Naval Medical Center
Disclosure: Nothing to disclose.

Coauthor(s)

Kenneth J Galeckas, MD, Assistant Professor, Department of Dermatology, Uniformed Services University of the Health Sciences; Staff Dermatologist, Director, Laser and Cosmetic Clinic, Intern and Medical Student Coordinator, Department of Dermatology, National Naval Medical Center
Kenneth J Galeckas, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Society for Dermatologic Surgery, and Association of Military Dermatologists
Disclosure: Nothing to disclose.

Medical Editor

Leonard Sperling, MD, Chair, Professor, Department of Dermatology, Uniformed Services University of the Health Sciences
Leonard Sperling, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center
Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Jeffrey P Callen, MD, Professor of Medicine, Chief, Division of Dermatology, University of Louisville School of Medicine
Jeffrey P Callen, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and American College of Rheumatology
Disclosure: Amgen Honoraria Consulting; Abbott Honoraria Consulting; Electrical Optical Sciences Honoraria Consulting; Centocor Honoraria Consulting; Genetech Honoraria Consulting; Celgene Honoraria Consulting

CME Editor

Glen H Crawford, MD, Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital
Glen H Crawford, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Phi Beta Kappa, and Society of USAF Flight Surgeons
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.